Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:38 PM
Ignite Modification Date:
2025-12-24 @ 2:38 PM
NCT ID:
NCT01481259
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically proven nonsquamous non-small cell lung cancer
* Stage IIIb-IV, according to AJCC 2010 Staging System
* Disease measurable
* Patients are currently receiving two-drug chemotherapy regimen containing a platinum-based drug as first-line therapy
* No chemotherapy or radiotherapy prior to first-line therapy
* Age between 18-75
* Performance status \<2
* No congestive heart failure, severe arrhythmia,and coronal atherosclerosis heart disease
* No uncontrolled metabolic disease, infection, and neurological disorders
* No other malignancies
* Signed study-specific consent form prior to study entry
Exclusion Criteria:
* Patients are currently receiving radiotherapy or any chemotherapy regimen other than two-drug containing a platinum-based drug as first-line therapy
* Pregnant or lactating women
* Patient having hepatitis B virus infection, active tuberculosis, or other infectious diseases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01481259
Study Brief:
Protocol Section:
NCT01481259